![Stefan Sanktjohanser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stefan Sanktjohanser
Chief Executive Officer at goetzpartners Management Consultants GmbH
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephan Goetz | M | 58 |
goetzpartners Corporate Finance GmbH
![]() goetzpartners Corporate Finance GmbH Investment ManagersFinance Part of goetzpartners Group GmbH & Co. KG, goetzpartners Corporate Finance GmbH is a Munich-based independent advisory firm that specializes in strategy, M&A, and transformation for entrepreneurial activities. goetzpartners' unique approach combines corporate finance and management consulting to create sustainable added value for clients in determining valid courses of action, reaching decisions, and implementing them. The German company was founded in 1991 by Stefan Sanktjohanser and Stephan Goetz, who have been the CEOs since then.
goetzpartners Management Consultants GmbH
![]() goetzpartners Management Consultants GmbH Miscellaneous Commercial ServicesCommercial Services goetzpartners Management Consultants GmbH provides strategic management consulting services. It specializes in the areas of realignment, sales optimization, restructuring, and post merger integration. The company is headquartered in Munich, Germany. | 33 years |
Michael Lee-Chin | M | 73 |
ITM Isotope Technologies Munich SE
![]() ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | 5 years |
Steffen Schuster | M | 59 |
ITM Isotope Technologies Munich SE
![]() ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | 13 years |
Udo Johannes Vetter | M | 69 |
ITM Isotope Technologies Munich SE
![]() ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | 18 years |
Tadd Seaton Wessel | M | - |
ITM Isotope Technologies Munich SE
![]() ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | 3 years |
Gunther Strothe | M | - |
ITM Isotope Technologies Munich SE
![]() ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | 8 years |
Oliver Buck | M | - |
ITM Isotope Technologies Munich SE
![]() ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | 12 years |
Manuel Salvisberg | M | - |
ITM Isotope Technologies Munich SE
![]() ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology ITM Isotope Technologies Munich SE is a leading radiopharmaceutical biotech company based in Garching, Germany. The German company aims to meet the needs of cancer patients, clinicians, and partners through excellence in development, production, and supply. ITM Isotope Technologies Munich SE strives to provide patients with more effective targeted treatment to improve clinical outcomes and quality of life. ITM is dedicated to providing a new generation of radiomolecular precision therapeutics and diagnostics for hard-to-treat tumors. With a broad precision oncology pipeline, including two phase III studies, ITM combines high-quality radioisotopes with a range of targeting molecules. The company was founded in 2004, and Steffen Schuster has been the CEO since 2011. | - |
Bernard Toupas | M | - |
goetzpartners Corporate Finance GmbH
![]() goetzpartners Corporate Finance GmbH Investment ManagersFinance Part of goetzpartners Group GmbH & Co. KG, goetzpartners Corporate Finance GmbH is a Munich-based independent advisory firm that specializes in strategy, M&A, and transformation for entrepreneurial activities. goetzpartners' unique approach combines corporate finance and management consulting to create sustainable added value for clients in determining valid courses of action, reaching decisions, and implementing them. The German company was founded in 1991 by Stefan Sanktjohanser and Stephan Goetz, who have been the CEOs since then. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ivo Polten | M | - |
goetzpartners Corporate Finance GmbH
![]() goetzpartners Corporate Finance GmbH Investment ManagersFinance Part of goetzpartners Group GmbH & Co. KG, goetzpartners Corporate Finance GmbH is a Munich-based independent advisory firm that specializes in strategy, M&A, and transformation for entrepreneurial activities. goetzpartners' unique approach combines corporate finance and management consulting to create sustainable added value for clients in determining valid courses of action, reaching decisions, and implementing them. The German company was founded in 1991 by Stefan Sanktjohanser and Stephan Goetz, who have been the CEOs since then. | 17 years |
Statistics
Country | Connections | % of total |
---|---|---|
Germany | 10 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stefan Sanktjohanser
- Personal Network